Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
NCT03176238
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
235
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Menopausal Breast Cancer
Interventions
DRUG:
everolimus
DRUG:
exemestane
Sponsor
Novartis Pharmaceuticals